INTERPRETIVE CRITERIA FOR DISK DIFFUSION TESTS USING 5-MICROGRAM CEFDINIR DISKS WITH RAPIDLY GROWING CLINICAL ISOLATES

被引:12
作者
JONES, RN
ERWIN, ME
GOODING, BB
机构
关键词
D O I
10.1128/JCM.30.4.1022-1023.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Preliminary interpretive zone diameter criteria were calculated for the 5-mu-g cefdinir disk diffusion test by using two potential MIC breakpoints (less-than-or-equal-to 0.5 and less-than-or-equal-to 1-mu-g/ml). The absolute agreement between tests ranged from 85.9 to 92.4%, and the false-susceptibility errors were principally contributed by the Enterobacter spp. (2.2% error). One proposed criterion was greater-than-or-equal-to 20-mm zone diameter (less-than-or-equal-to 1-mu-g/ml) for susceptibility and less-than-or-equal-to 16-mm zone diameter (> 2-mu-g/ml) for resistance to cefdinir. Clinical laboratory users of the disk diffusion method should be cautioned about the possibility of very major interpretive errors among enterobacter isolates.
引用
收藏
页码:1022 / 1023
页数:2
相关论文
共 9 条
[1]   INVITRO ACTIVITY EVALUATIONS OF CEFDINIR (FK482, CI-983, AND PD134393) - A NOVEL ORALLY-ADMINISTERED CEPHALOSPORIN [J].
BRIGGS, BM ;
JONES, RN ;
ERWIN, ME ;
BARRETT, MS ;
JOHNSON, DM .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1991, 14 (05) :425-434
[2]   CEFIXIME DISK SUSCEPTIBILITY TEST CRITERIA [J].
FUCHS, PC ;
BARRY, AL ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (04) :647-649
[3]  
Jones R. N., 1988, Antimicrobic Newsletter, V5, P1, DOI 10.1016/0738-1751(88)90015-9
[4]   PRELIMINARY ANTIMICROBIAL SUSCEPTIBILITY INTERPRETIVE CRITERIA FOR CEFETAMET (RO 15-8074) AND CEFTERAM (RO 19-5247) DISK TESTS [J].
JONES, RN ;
BARRY, AL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) :1796-1799
[5]   DISK DIFFUSION SUSCEPTIBILITY TESTING FOR LY163892 (KT-3777), A NEW ORALLY-ADMINISTERED 1-CARBACEPHEM [J].
JONES, RN ;
BARRY, AL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (04) :770-773
[6]  
MINE Y, 1988, J ANTIBIOT, V41, P1873, DOI 10.7164/antibiotics.41.1873
[7]   PHARMACOKINETICS OF FK482, A NEW ORALLY ACTIVE CEPHALOSPORIN, IN ANIMALS [J].
SAKAMOTO, H ;
HIROSE, T ;
NAKAMOTO, S ;
HATANO, K ;
SHIBAYAMA, F ;
KIKUCHI, H ;
MINE, Y ;
KUWAHARA, S .
JOURNAL OF ANTIBIOTICS, 1988, 41 (12) :1896-1905
[8]  
1990, M7A2 NAT COMM CLIN L
[9]  
1990, M2A4 NAT COMM CLIN L